Project Details
Description
A multicenter, prospective, open-label, clinical study to assess the effect of using a new risk score approach to select the most appropriate prophylaxis regimen for reaching a favorable outcome, when hemophilia A patients switch from standard half-lif
| Status | Active |
|---|---|
| Effective start/end date | 9/28/22 → 9/30/27 |
Funding
- BAYER CORP
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.